Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Levodopa”

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT06180720
What this trial is testing

Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in the Postprandial State in Healthy Chinese Subjects

Who this might be right for
Healthy
The Affiliated Hospital of Qingdao University 36
Large-scale testing (Phase 3)Study completedNCT03670953
What this trial is testing

Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations

Who this might be right for
Parkinson's Disease (Disorder)
Impax Laboratories, LLC 630
Early research (Phase 1)Study completedNCT02812394
What this trial is testing

Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets

Who this might be right for
Parkinson Disease
Acorda Therapeutics 24
Not applicableStudy completedNCT04956939
What this trial is testing

Levodopa Response and Gut Microbiome in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Rush University Medical Center 38
Testing effectiveness (Phase 2)WithdrawnNCT00947037
What this trial is testing

Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study

Who this might be right for
Parkinson's Disease
Intec Pharma Ltd.
Testing effectiveness (Phase 2)Study completedNCT00279825
What this trial is testing

Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Impax Laboratories, LLC 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT02726386
What this trial is testing

A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease

Who this might be right for
Parkinson's Disease
NeuroDerm Ltd. 214
Testing effectiveness (Phase 2)Study completedNCT01176435
What this trial is testing

Trial of L-DOPA as a Treatment to Improve Vision in Albinism

Who this might be right for
Albinism
University of Minnesota 45
Large-scale testing (Phase 3)Study completedNCT02337725
What this trial is testing

TVP-1012 (1 mg) in Early Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Takeda 244
Not applicableLooking for participantsNCT07313176
What this trial is testing

Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease

Who this might be right for
Advanced Parkinson Disease
Britannia Pharmaceuticals Ltd. 215
Testing effectiveness (Phase 2)Study completedNCT01568047
What this trial is testing

Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients

Who this might be right for
Parkinson's Disease
Bial - Portela C S.A. 40
Large-scale testing (Phase 3)Study completedNCT00203957
What this trial is testing

Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa

Who this might be right for
Parkinson's Disease
University of Chicago 10
Early research (Phase 1)Study completedNCT01533077
What this trial is testing

Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 18
Not applicableActive Not RecruitingNCT06107426
What this trial is testing

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

Who this might be right for
Parkinson's Disease (PD)
AbbVie 427
Testing effectiveness (Phase 2)Study completedNCT00009048
What this trial is testing

EMD 128130 for the Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 30
Post-approval studies (Phase 4)Study completedNCT00143026
What this trial is testing

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

Who this might be right for
Parkinson's Disease
Novartis 184
Post-approval studies (Phase 4)Study completedNCT00307450
What this trial is testing

Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease

Who this might be right for
Parkinson's Disease
Technische Universität Dresden 34
Large-scale testing (Phase 3)Study completedNCT01736891
What this trial is testing

Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations

Who this might be right for
Parkinson´s Disease
Chongqing Fortune Pharmaceutical Co., Ltd. 268
Not applicableStudy completedNCT02701803
What this trial is testing

Parkinson's KinetiGraph, PKG in Patients With Deep Brain Stimulation and Continuous Levodopa Infusion Therapy

Who this might be right for
Parkinson's Disease
Hospital District of Helsinki and Uusimaa 8
Large-scale testing (Phase 3)Study completedNCT01130493
What this trial is testing

Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

Who this might be right for
Parkinson's Disease
Impax Laboratories, LLC 110
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation